GSK stock jumped early Wednesday after the drugmaker reported adjusted earnings of $1.20 per share on $10.06 billion in first-quarter sales.
The post GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs appeared first on Investor's Business Daily.